Lexicon Pharmaceuticals, Inc. (LXRX)

Last Three Months

25-Jan-24 -- 24-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Diagnostic Substances

Drugs

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

25

0

9

+1

0

+2

0

+3

Two Year Chart

25-Apr-22 -- 24-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
13-Mar-24 9:22 PM View:	13-Mar-24 Grant $124.88M	Artal International Sca Director 10% Owner		Lexicon Pharmaceuticals, Inc. - LXRX	100% 0 to 1.15M	0	0	--	--	Show Txns Hide Txns

29-Feb-24 4:30 PM View:	28-Feb-24 Payment of Exercise ($63.95K)	Main Alan J EVP, Innov & Chem Sciences		Lexicon Pharmaceuticals, Inc. - LXRX	20% 212.59K to 255.72K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 4:28 PM View:	28-Feb-24 Payment of Exercise ($81.91K)	Granowitz Craig B SVP, Chief Medical Officer		Lexicon Pharmaceuticals, Inc. - LXRX	214% 15.19K to 47.63K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 10:00 PM View:	28-Feb-24 Payment of Exercise ($30.90K)	Alexander Kristen VP, Finance and Accounting		Lexicon Pharmaceuticals, Inc. - LXRX	57% 30.35K to 47.8K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 10:00 PM View:	28-Feb-24 Payment of Exercise ($63.80K)	Kassler-Taub Kenneth B. SVP, Regulatory & QA		Lexicon Pharmaceuticals, Inc. - LXRX	36% 119.63K to 162.67K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 10:00 PM View:	28-Feb-24 Payment of Exercise ($58.75K)	McDermott Wendy VP, Human Resources		Lexicon Pharmaceuticals, Inc. - LXRX	85% 28.48K to 52.69K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 10:00 PM View:	28-Feb-24 Payment of Exercise ($160.79K)	Coats Lonnel Chief Executive Officer Director		Lexicon Pharmaceuticals, Inc. - LXRX	20% 914.36K to 1.1M	0	0	--	--	Show Txns Hide Txns

29-Feb-24 10:00 PM View:	28-Feb-24 Payment of Exercise ($67.08K)	Crum Brian T SVP, General Counsel & Secr.		Lexicon Pharmaceuticals, Inc. - LXRX	32% 134.8K to 177.5K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 10:00 PM View:	28-Feb-24 Payment of Exercise ($98.75K)	Wade Jeffrey L President and CFO		Lexicon Pharmaceuticals, Inc. - LXRX	23% 264.34K to 324.21K	0	0	--	--	Show Txns Hide Txns